Leuprorelin

from Wikipedia, the free encyclopedia
Structural formula
Structure of leuprorelin
General
Non-proprietary name Leuprorelin
other names

5-Oxo-Pro-His-Trp-Ser-Tyr-d-Leu-Leu-Arg-Pro-NH-C2H5

Molecular formula C 59 H 84 N 16 O 12
External identifiers / databases
CAS number
  • 53714-56-0
  • 74381-53-6 (leuprorelin acetate )
EC number 633-395-9
ECHA InfoCard 100.161.466
PubChem 657181
ChemSpider 571356
DrugBank DB00007
Wikidata Q907160
Drug information
ATC code

L02 AE02

Drug class

Antiandrogens

properties
Molar mass 1209.40 g · mol -1
safety instructions
Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS labeling of hazardous substances

Acetate salt

no GHS pictograms
H and P phrases H: no H-phrases
P: no P-phrases
Toxicological data

137 mg kg −1 ( LD 50mouseiv , acetate)

As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Leuprorelin is a GnRH analog that stops hormone production and is used to artificially lower testosterone or estrogen levels in the blood. It is a peptide made up of nine amino acids .

indication

Leuprorelin is used among other things at

Others

Leuprorelin is subject to a prescription in Germany. When protected from light and stored below 25 ° C, two-chamber syringes have a shelf life of 36 months. The application interval for monthly deposits may not exceed 32 days. Takeda achieved net sales of around EUR 8 billion with leuprorelin products in the 2012 financial year.

Trade names

Monopreparations

Enantone (D, A), Trenantone (D, A), Sixantone (D, A), Lucrin (CH), various generics (D, CH)

Individual evidence

  1. Data sheet Leuprolide acetate salt from Sigma-Aldrich , accessed on May 29, 2011 ( PDF ).
  2. Entry on leuprorelin in the ChemIDplus database of the United States National Library of Medicine (NLM) .
  3. GenScript catalog ( Memento of 17 October 2006 at the Internet Archive ), accessed on June 13 of 2007.
  4. Hartmut Göbel: Cluster headache and other trigemino-autonomic headache disorders . In: The headache . Springer Berlin Heidelberg, Berlin, Heidelberg 2012, ISBN 978-3-642-20694-8 , pp. 497-538 , doi : 10.1007 / 978-3-642-20695-5_9 ( springer.com [accessed October 22, 2019]).
  5. ^ Takeda Pharmaceutical Company Limited .